Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Syndrome (CIS)”

34 trials

Showing 20 of 34 results

Not applicableStudy completedNCT00787657
What this trial is testing

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Bayer 1,723
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Not applicableStudy completedNCT04038541
What this trial is testing

Prebiotic vs Probiotic in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Columbia University 37
Not applicableEnded earlyNCT00819897
What this trial is testing

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

Who this might be right for
Clinically Isolated Syndrome
Centre Hospitalier Universitaire de Nice 37
Not applicableStudy completedNCT01592474
What this trial is testing

Evaluation of Brain Atrophy in CIS Patients on Avonex

Who this might be right for
Multiple Sclerosis
University at Buffalo 180
Not applicableStudy completedNCT01414816
What this trial is testing

Betaferon® Regulatory Post-Marketing Surveillance

Who this might be right for
Multiple SclerosisClinically Isolated System
Bayer 355
Large-scale testing (Phase 3)Study completedNCT00622700
What this trial is testing

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 618
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154
Testing effectiveness (Phase 2)Study completedNCT00094172
What this trial is testing

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Large-scale testing (Phase 3)Study completedNCT00666887
What this trial is testing

Minocycline in Clinically Isolated Syndromes (CIS)

Who this might be right for
Clinically Isolated SyndromesEarly Single Relapse of Multiple Sclerosis
Dr. Luanne Metz 142
Post-approval studies (Phase 4)UnknownNCT00910598
What this trial is testing

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Amphia Hospital 60
Large-scale testing (Phase 3)Study completedNCT01817166
What this trial is testing

Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 316
Not applicableStudy completedNCT02695394
What this trial is testing

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Who this might be right for
Multiple Sclerosis (MS)Clinically Isolated Syndrome (CIS)
Charite University, Berlin, Germany 60
Early research (Phase 1)Study completedNCT01031199
What this trial is testing

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Who this might be right for
Positron-Emission TomographyMultiple Sclerosis
Bayer 16
Not applicableEnrolling By InvitationNCT07183020
What this trial is testing

Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome (CIS)
Skripuletz, Thomas Prof. Dr. 1,142
Large-scale testing (Phase 3)Study completedNCT01167426
What this trial is testing

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 148
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Galapagos NV 15
Not applicableStudy completedNCT03541226
What this trial is testing

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University Hospital, Lille 134
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Large-scale testing (Phase 3)Study completedNCT00725985
What this trial is testing

Oral Cladribine in Early Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 617
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation